Posted by Michael Wonder on 20 Apr 2021
NICE’s five year strategy sets a ‘positive vision for the future’
20 April 2021 - The pharma industry has responded to the NICE new five year strategy, announced yesterday.
In response to NICE’s new guideline recommendations, Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry commented: “Pharmaceutical companies are working on thousands of exciting new medicines and treatments, from rare disease gene therapies to mRNA vaccines for cancer.”
